Another successful trial at MediSphere Medical Research Center, LLC:
The U.S. Food and Drug Administration (FDA) has approved Trulance™ (plecanatide) for the treatment of adults with chronic constipation of unknown cause (CIC). Trulance™ is the first drug designed to replicate a naturally occurring compound thought to stimulate fluid secretion in the gastrointestinal (GI) tract. Based on pre-clinical studies, this results in a stool consistency associated with more regular bowel function. * Synergy’s plan is to make Trulance™ available in the U.S. later this quarter. (Excerpted from press release)
The MediSphere team extends its deepest gratitude to all of our patients who participate in clinical trials that bring new medicines to market.
